Diener HC

No ORCID on file · 2 papers in corpus

2021

Efficacy and safety of fremanezumab in patients with episodic and chronic migraine with documented inadequate response to 2 to 4 classes of migraine preventive medications over 6 months of treatment in the phase 3b FOCUS study.

The journal of headache and pain ·doi:10.1186/s10194-021-01279-7

BackgroundFremanezumab, a fully humanized monoclonal antibody (IgG2Δa) selectively targets the calcitonin gene-related peptide and has proven efficacy for the preventive treatment of migraine. In this study, we evaluated the long-term effic…

2014

Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine.

European journal of neurology ·doi:10.1111/ene.12393

Background and purposeOnabotulinumtoxinA was effective and well tolerated for prophylaxis of headache in patients with chronic migraine (CM) in two randomized, double-blind, placebo-controlled, phase 3 trials. To further assess the safety a…